Mouse T cells receive costimulatory signals from LIGHT, a TNF family member

Blood

Volumn 100, Issue 9, 2002, Pages 3279-3286

  Shi, Guixiu ^a   Luo, Hongyu ^a   Wan, Xiaochun ^b   Salcedo, Theodora W ^b   Zhang, Jun ^c   Wu, Jiangping ^a,d  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Pavilion DeSeve ^*

^d NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; FAS LIGAND; LYMPHOKINE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; PROTEIN LIGHT; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CROSS LINKING; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVATION; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0036838630     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-05-1404     Document Type: Article

References (33)

1. Mauri DN, Ebner R, Montgomery RI, et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpes virus entry mediator. Immunity: 1998;8:21-30.
2. Tamada K, Shimozaki K, Chapoval Al, et al. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol. 2000;164:4105-4110.
3. Zhang J, Salcedo TW, Wan X, et al. Modulation of T-cell responses to alloantigens by TR6/DcR3. J Clin Invest. 2001;107:1459-1468.
4. Yu KY, Kwon B, Ni J, Zhai Y, Ebner R, Kwon BS. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem. 1999;274:13733-13736.
5. Tamada K, Shimozaki K, Chapoval Al, et al. Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat Med. 2000;6:283-289.
6. Kwon BS, Tan KB, Ni J, et al. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem. 1997;272:14272-14276.
7. Zhai Y, Guo R, Hsu TL, et al. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest. 1998;102:1142-1151.
8. Rooney IA, Butrovich KD, Glass AA, et al. The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J Biol Chem. 2000;275:14307-14315.
9. Browning JL, Sizing ID, Lawton P, et al. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes. J Immunol. 1997;159:3288-3298.
10. + T lymphocytes. J Immunol. 1994;152:1523-1531.
11. van Essen D, Kikutani H, Gray D. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature. 1995;378:620-623.
12. Wiley SR, Goodwin RG, Smith CA. Reverse signaling via CD30 ligand. J Immunol. 1996;157:3635-3639.
13. + B cells. J Immunol. 2000;165:786-794.
14. Eissner G, Kirchner S, Lindner H, et al. Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages. J Immunol. 2000;164:6193-6198.
15. Chen NJ, Huang MW, Hsieh SL. Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine. J Immunol. 2001;166:270-276.
16. Suzuki I, Fink PJ. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J Exp Med. 1998;187:123-128.
17. + T cells. Proc Natl Acad Sci U S A. 2000;97:1707-1712.
18. + T cells. J Immunol. 2000;165:5537-5543.
19. Chou AH, Tsai HF, Lin LL, Hsieh SL, Hsu PI, Hsu PN. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. J Immunol. 2001;167:1347-1352.
20. Pitti RM, Marsters SA, Lawrence DA, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature. 1998;396:699-703.
21. MigoneT-S, Zhang J, Luo X, et al. TL1A is a novel ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity. 2002;16:479-492.
22. d-specific TCR transgenic mice transplanted with allogenic hearts under the cover of a short-term rapamycin treatment. J Immunol. 1996;157:4297-4308.
23. Luo H, Chen H, Daloze P, Chang PY, St-Louis G, Wu J. Inhibition of in vitro immunoglobulin production by rapamycin. Transplantation. 1992;53:1071-1076.
24. Luo H, Chen H, Daloze P, St-Louis G, Wu J. Anti-CD28 antibody- and IL-4-induced human T cell proliferation is sensitive to rapamycin. Clin Exp Immunol. 1993;94:371-376.
25. Sha WC, Nelson CA, Newberry RD, Franz DM, Russell JH, Loh DY. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature. 1988;335:271-274.
26. Morel Y, Schiano de Colella JM, Harrop J, et al. Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J Immunol. 2000;165:4397-4404.
27. Shaikh RB, Santee S, Granger SW, et al. Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J Immunol. 2001;167:6330-6337.
28. Wang J, Lo JC, Foster A, et al. The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J Clin Invest. 2001;108:1771-1780.
29. Brenner B, Koppenhoefer U, Lepple-Wienhues A, et al. The CD40 ligand directly activates T-lymphocytes via tyrosine phosphorylation dependent PKC activation. Biochem Biophys Res Commun. 1997;239:11-17.
30. Brenner B, Koppenhoefer U, Grassme H, Kun J, Lang F, Gulbins E. Evidence for a novel function of the CD40 ligand as a signalling molecule in T-lymphocytes. FEBS Lett. 1997;417:301-306.
31. Xavier R, Seed B. Membrane compartmentation and the response to antigen. Curr Opin Immunol. 1999;11:265-269.
32. Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science. 1999;283:680-682.
33. Yashiro-Ohtani Y, Zhou XY, Toyo-Oka K, et al. Non-CD28 costimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of TCR with rafts. J Immunol. 2000;164:1251-1259.